CN113913451A - Construction method of pichia pastoris engineering bacteria for producing inositol - Google Patents

Construction method of pichia pastoris engineering bacteria for producing inositol Download PDF

Info

Publication number
CN113913451A
CN113913451A CN202010653538.8A CN202010653538A CN113913451A CN 113913451 A CN113913451 A CN 113913451A CN 202010653538 A CN202010653538 A CN 202010653538A CN 113913451 A CN113913451 A CN 113913451A
Authority
CN
China
Prior art keywords
inositol
pichia pastoris
gene
pgi
chr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010653538.8A
Other languages
Chinese (zh)
Other versions
CN113913451B (en
Inventor
赵伟
杨倩
何庆
段莹莹
王健
张雷达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Fuyang Biotechnology Co ltd
Original Assignee
Shandong Fuyang Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Fuyang Biotechnology Co ltd filed Critical Shandong Fuyang Biotechnology Co ltd
Priority to CN202010653538.8A priority Critical patent/CN113913451B/en
Publication of CN113913451A publication Critical patent/CN113913451A/en
Application granted granted Critical
Publication of CN113913451B publication Critical patent/CN113913451B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • C12N9/92Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01009Glucose-6-phosphate isomerase (5.3.1.9)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y505/00Intramolecular lyases (5.5)
    • C12Y505/01Intramolecular lyases (5.5.1)
    • C12Y505/01004Inositol-3-phosphate synthase (5.5.1.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a construction method of a pichia pastoris engineering strain for producing inositol, belonging to the technical field of biological engineering. The invention discloses a construction method of a pichia pastoris engineering strain for generating inositol, which provides a new method for expressing the inositol by using pichia pastoris GS115 by knocking out a glycolysis key gene pgi and an inositol biosynthesis negative regulation gene PAS _ chr-1_0033 in pichia pastoris GS115 and overexpressing an inositol-3-phosphate synthase (ino1) gene. The invention uses the pichia pastoris as an expression host for the first time, realizes the practical technology of expressing the inositol by the pichia pastoris, adopts a high-density fermentation culture method, and finally ensures that the yield of the inositol of the engineering bacteria in a 5L fermentation tank can reach 32.3 g/L.

Description

Construction method of pichia pastoris engineering bacteria for producing inositol
Technical Field
The invention relates to the technical field of bioengineering, in particular to a construction method of a pichia pastoris engineering bacterium for producing inositol.
Background
Inositol in inositol is most well known and is known for its presence in muscle tissue. Inositol has a wide range of uses, in the feed industry as a bio-enhancer to promote growth and prevent death in livestock, and in the food industry as a dietary supplement to prevent fat deposition in humans, particularly in the cardiovascular system.
At present, the main raw materials for producing inositol in China are byproducts in the processing process of agricultural products, such as steeping liquor of corn, rice bran and the like. In order to reduce energy consumption and pollution, the preparation of inositol by biological methods is receiving more and more attention from researchers, and mainly comprises a microbial enzyme catalysis method and a microbial fermentation method. The fermentation method mainly uses mixed saccharides as raw materials, uses saccharomycetes, escherichia coli and bacillus subtilis as main production bacteria, and prepares the high-purity inositol by fermenting and secreting inositol into fermentation liquor, treating the fermentation liquor, concentrating and crystallizing.
In large-scale production, escherichia coli is easily polluted by bacteriophage, and bacillus subtilis is difficult to achieve higher thallus density, so that the saccharomycete is the most suitable bacterial strain for producing inositol through industrial fermentation. The utilization of yeast for producing inositol is based on the theoretical research on the metabolic pathway of inositol. Control of inositol biosynthesis by s.cerevisiae (ino +) inositol secreting yeast was reported in 1976. Cerevisiae found at least 3 gene sites in 1981 to repress the synthesis of key enzymes for myo-inositol biosynthesis. In 1990, the gene engineering technology is utilized to obtain Saccharomyces cerevisiae YS2 with the defect of opi1 gene of negative regulatory factor for inositol biosynthesis and multiple copies of INO1 gene, and a method for preparing inositol by utilizing the gene engineering technology is provided, but the yield of the inositol in the shake flask of YS2 is only 1.021 g/L.
Pichia pastoris is one of the most excellent exogenous gene expression systems with the most extensive application at present, and has been successfully expressedNearly 700 foreign proteins are obtained, and the biomass (OD) of the cells is 48h600) Can reach 395. Therefore, the problem to be solved by the technical personnel in the field is to provide a construction method of a pichia pastoris engineering bacterium for producing inositol.
Disclosure of Invention
In view of the above, the invention provides a construction method of a pichia pastoris engineering bacterium for producing inositol, and the yield of the inositol is further improved.
In order to achieve the purpose, the invention adopts the following technical scheme:
a construction method of a pichia pastoris engineering bacterium for producing inositol comprises the following specific steps:
(1) knocking out a glycolysis key gene pgi by using pichia pastoris GS115 as an initial strain to obtain a pgi gene knocked-out strain delta pgi-GS 115;
(2) knocking out a negative regulation gene PAS _ chr-1_0033 of inositol biosynthesis of the strain delta pgi-GS115 to obtain a strain delta PAS _ chr-1_0033 delta pgi-GS115 with the PAS _ chr-1_0033 gene knocked out;
(3) an inositol-3-phosphate synthase gene ino1 is overexpressed in a strain delta PAS _ chr-1_0033 delta pgi-GS115, and a pichia pastoris engineering strain delta PAS _ chr-1_0033 delta pgi-GS115(ino +) for producing inositol is constructed.
Further, the construction method of the pichia pastoris engineering bacterium for producing the inositol comprises the following specific steps:
(1) amplifying zeocin gene and pgi gene upstream and downstream 400bp sequence by PCR;
(2) connecting the 3 gene fragments by using overlapping PCR to obtain a sequence zeocin-UD;
(3) transferring the sequence zeocin-UD into a pichia pastoris GS115 competent cell through electrotransformation, and screening to obtain an engineering bacterium delta pgi-GS115 with pgi gene knocked out;
(4) amplifying 400bp sequences of the upstream and downstream of a G418 gene and an inositol biosynthesis negative regulation gene PAS _ chr-1_0033 by PCR, and connecting the sequences by adopting overlapping PCR to obtain G418-UD;
(5) transferring G418-UD into a delta pgi-GS115 competent cell in an electrotransformation mode, and screening to obtain an engineering bacterium delta PAS _ chr-1_0033 delta pgi-GS115 with a PAS _ chr-1_0033 gene knocked out;
(6) the constructed pPIC9-ino1 plasmid is transferred into a strain delta PAS _ chr-1-0033 delta pgi-GS115 through electrotransformation, and the strain delta PAS _ chr-1-0033 delta pgi-GS115(ino +) engineering strain is obtained through screening.
Further, the application of the pichia pastoris engineering bacteria for producing the inositol in preparing products containing the inositol.
The invention utilizes a bioinformatics method to search homologous protein of inositol biosynthesis transcription inhibitor gene opi1 in pichia pastoris genome, and finds 100% homology of gene PAS _ chr-1_0033 and opi1 protein through sequence comparison.
Through the technical scheme, compared with the prior art, the invention discloses a construction method of a pichia pastoris engineering bacterium for generating inositol, and provides a novel method for expressing the inositol by using pichia pastoris GS115 by knocking out a glycolysis key gene pgi and an inositol biosynthesis negative regulation gene PAS _ chr-1_0033 in the pichia pastoris GS115 and overexpressing an inositol-3-phosphate synthase (ino1) gene.
The invention uses the pichia pastoris as an expression host for the first time, realizes the practical technology of expressing the inositol by the pichia pastoris, adopts a high-density fermentation culture method, and finally ensures that the yield of the inositol of the engineering bacteria in a 5L fermentation tank can reach 32.3 g/L. At present, most of hosts for producing inositol by using a biological fermentation technology adopt escherichia coli, which is easily polluted by bacteriophage and has a long fermentation period. The Pichia pastoris engineering bacteria for producing inositol constructed by the invention can obtain higher thallus density, and simultaneously greatly reduce the influence of phage pollution on large-scale inositol production.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the provided drawings without creative efforts.
FIG. 1 is a PCR-verified nucleic acid gel electrophoresis of a pgi gene knockout nucleic acid of Pichia pastoris GS115 of the present invention;
wherein M is a DNA Marker; CK is wild type GS115 genome PCR product; 1 is a positive clone genome PCR product obtained by colony PCR screening;
FIG. 2 is a nucleic acid gel electrophoresis diagram showing that PAS _ chr-1_0033 gene in Δ pgi-GS115 is knocked out by PCR verification according to the present invention;
wherein M is a DNA Marker; CK is wild type GS115 genome PCR product; 1-3 are 3 colony genome PCR products of resistance screening, and only 3 are positive clones obtained by colony PCR screening;
FIG. 3 is a map of a pUC57-ino1 vector of the present invention;
FIG. 4 is a map of the pPIC9 vector of the present invention;
FIG. 5 is the restriction enzyme digestion identification result of recombinant plasmid pPIC9-ino1 of the present invention;
wherein M is a DNA Marker; 1-6 are double digestion products of recombinant plasmid pPIC9-ino1 respectively;
FIG. 6 is a vector map of recombinant plasmid pPIC9-ino1 of the present invention;
FIG. 7 is a graph showing the yield of inositol in a 5L fermentor of the present invention, with an inositol peak time of 12.265 min.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1 knockout of glycolytic Key Gene pgi in Pichia pastoris GS115
GS115 genome and pPIZ alpha are respectively used as templates to design and synthesize primers AP-F/R, CP-F/R, zeocin-F/R. The specific primer sequences are as follows:
AP-F:5’-ACTTAGAAACGTTGCTTTGACGTAATAGGTCACCTGTG-3’;SEQ ID NO.1;
AP-R:5’-GGCACTGGTCAACTTGGCCATTTTATCAATTGGTTGGAGTT-3’;SEQ ID NO.2;
CP-F:5’-CGAGGAGCAGGACTGAGGCGTTCTAGTTATAGAGAT-3’;SEQ ID NO.3;
CP-R:5’-CTAAACATCCCAAAGTTCAAAAACTCATTGCTGGCT-3’;SEQ ID NO.4;
zeocin-F:5’-AACTCCAACCAATTGATAAAATGGCCAAGTTGACCAGTGCC-3’;SEQ ID NO.5;
zeocin-R:5’-ATCTCTATAACTAGAACGCCTCAGTCCTGCTCCTCG-3’;SEQ ID NO.6。
and respectively carrying out PCR amplification on the DNA fragments AP and CP by using the GS115 genome as a template and the AP-F/R and the CP-F/R as primers, wherein the PCR reaction system and the reaction program are consistent. And (3) PCR reaction system: 2x Phanta Max Buffer 25. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 1 microliter of template; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 50. mu.l of O. Reaction procedure: pre-denaturation at 95 ℃ for 10 min; denaturation at 95 ℃ for 30s, annealing at 59 ℃ for 30s, extension at 72 ℃ for 1min, and 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
Taking pPIZ alpha as a template and zeocin-F/R as a primer, and carrying out PCR amplification on a DNA fragment zeocin; and (3) PCR reaction system: 2x PhantaMax Buffer 25. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 100 × template 1 μ l; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 50. mu.l of O. Reaction procedure: pre-denaturation at 95 ℃ for 5 min; denaturation at 95 ℃ for 30s, annealing at 59 ℃ for 30s, extension at 72 ℃ for 1min for 30s, 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
The fragments AP, CP and zeocin were then ligated by overlap PCR using primers AP-F and CP-R to obtain the sequence zeocin-UD. And (3) PCR reaction system: 2x Phanta Max Buffer 25. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 1. mu.l of each of the three fragment templates; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 50. mu.l of O. PCR reaction procedure: pre-denaturation at 95 ℃ for 10 min; denaturation at 95 ℃ for 45s, annealing at 57.5 ℃ for 45s, extension at 72 ℃ for 2min, 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃. To be provided withThe gene is transferred into GS115 competent cells in an electrotransformation mode, and a pgi gene is knocked out by utilizing a homologous recombination method (the nucleotide sequence of the pgi gene is shown in SEQ ID NO. 7). Resistance screening is carried out by bleomycin (zeocin, 300 mu g/mL), positive clone is screened by colony PCR, genome is extracted for PCR verification, primers are respectively AP-F and CP-R, PCR reaction system: 2x PhantaMax Buffer 10. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 1 microliter of template; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 20. mu.l of O. Reaction procedure: pre-denaturation at 95 ℃ for 10 min; denaturation at 95 ℃ for 30s, annealing at 57.5 ℃ for 30s, extension at 72 ℃ for 2min, and 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃. The PCR verification result is shown in FIG. 1, and the size of the strip of the pgi gene is between 1.5k and 3k if the pgi gene is not knocked out; if knocked out, the size of the band should be around 1.2 k. The constructed new strain with the pgi gene knocked out was named as Δ pgi-GS 115.
Example 2 knockout of inositol biosynthesis negative regulator Gene PAS _ chr-1_0033 in Δ pgi-GS115
GS115 and pUG6 are respectively taken as templates to design and synthesize primers AZ-F/R, CZ-F/R, G418-F/R.
The specific primer sequences are as follows:
AZ-F:5’-CGTTAGCCAATAGTGTCCCTGCATTCTGGTTCCTCC-3’;SEQ ID NO.8;
AZ-R:5’-GTATTCTGGGCCTCCATGTCTGTTTGGCAGATTCTGTGTC-3’;SEQ ID NO.9;
CZ-F:5’-TGAATGCTGGTCGCTATACTGATTATTCTATAGATTTAGGA-3’;SEQ ID NO.10;
CZ-R:5’-TTTGGCTCGTTCGACTGCCATGGTCGTCAA-3’;SEQ ID NO.11;
G418-F:5’-GACACAGAATCTGCCAAACAGACATGGAGGCCCAGAATAC-3’;SEQ ID NO.12;
G418-R:5’-TCCTAAATCTATAGAATAATCAGTATAGCGACCAGCATTCA-3’;SEQ ID NO.13。
respectively carrying out PCR amplification on DNA fragments AZ and CZ by taking the GS115 genome as a template and AZ-F/R and CZ-F/R as primers; the PCR reaction system and the reaction procedure are consistent. And (3) PCR reaction system: 2x Phanta Max Buffer 25. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 1 microliter of template; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 50. mu.l of O. Reaction procedure: pre-denaturation at 95 ℃ for 10 min; denaturation at 95 ℃ for 30 s; annealing at 60 ℃ for 30 s; extending for 1min at 72 ℃; 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
PCR amplifying a DNA fragment G418 by taking pUG6 as a template and G418-F/R as a primer; and (3) PCR reaction system: 2x Phanta Max Buffer 25. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 100 × template 1 μ l; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 50. mu.l of O. PCR reaction procedure: pre-denaturation at 95 ℃ for 5 min; denaturation at 95 ℃ for 30s, annealing at 60 ℃ for 30s, extension at 72 ℃ for 1min for 30s, 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
Then overlapping PCR is carried out by using primers AZ-F and CZ-R to connect the fragments AZ, CZ and G418, and the reaction system: 2x PhantaMax Buffer 25. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 1. mu.l of each of the three fragment templates; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 50. mu.l of O. PCR reaction procedure: pre-denaturation at 95 ℃ for 10 min; denaturation at 95 ℃ for 45s, annealing at 62 ℃ for 45s, extension at 72 ℃ for 1min for 30s, 30 cycles; extending for 10min at 72 ℃; preserving the heat at 4 ℃ to obtain G418-UD. Transferred into a delta pgi-GS115 competent cell in an electrotransformation way, and a PAS _ chr-1_0033 gene is knocked out by utilizing a homologous recombination method (the nucleotide sequence of the PAS _ chr-1_0033 gene is shown in SEQ ID NO. 14). G418(500 mu G/mL) is used for resistance screening, positive clones are screened by colony PCR, genomes are extracted for PCR verification, primers are AZ-F and CZ-R respectively, and a PCR reaction system is as follows: 2x PhantaMax Buffer 10. mu.l; dNTP Mix (10mM each) 1. mu.l; phanta Max Super-Fidelity DNA Polymerase 0.6. mu.l; 1 microliter of template; 0.1. mu.l of each of the upstream and downstream primers (100. mu.M); ddH2Make up to 20. mu.l of O. PCR reaction procedure: pre-denaturation at 95 ℃ for 5 min; denaturation at 95 ℃ for 30s, annealing at 62 ℃ for 30s, extension at 72 ℃ for 2min, and 30 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃. The PCR result is shown in FIG. 2, if PAS _ chr-1_0033 gene is amplified, the band is located between 1k and 2k, if PAS _ chr-1_0033 gene is knocked out, the band is located between 750bp and 1000bp, and only lane 3 is positive clone obtained by colony PCR screening. Nomenclature of the New strains constructedIs Δ PAS _ chr-1_0033 Δ pgi-GS 115.
Example 3 construction of Δ PAS _ chr-1_0033 Δ pgi-GS115(ino +) engineering bacteria
The ino1 gene (the nucleotide sequence of the ino1 gene is shown in SEQ ID NO.15) is completely synthesized by combining the codon bias of pichia pastoris, EcoR I and XhoI restriction enzyme sites are respectively introduced into the 5 'end and the 3' end of the gene, the synthesized gene is connected to a pUC57 vector and is named as pUC57-ino1, and the vector map is shown in figure 3.
Plasmids pUC57-ino1 and pPIC9 (map as shown in figure 4) were subjected to EcoR I and Xho I double digestion respectively; the double enzyme digestion reaction condition is water bath at 37 ℃ for 2-3 h. And (3) respectively carrying out gel recovery on the double digestion products to obtain an ino1 fragment with two ends respectively provided with EcoR I and Xho I digestion sites and a pPIC9 vector, and connecting the T4 DNA ligase at 4 ℃ overnight. The ligation products were transformed into competent cells of the large intestine DH 5. alpha. and positive clones were screened with ampicillin (50. mu.g/mL), plasmids were extracted and enzyme digestion verified, the results are shown in FIG. 5, where the plasmid enzyme digestion in lanes 2 and 6 was verified correctly. The constructed recombinant expression plasmid containing the ino1 gene was named pPIC9-ino1, and the map is shown in FIG. 6.
The constructed pPIC9-ino1 plasmid is transferred into a strain delta PAS _ chr-1-0033 delta pgi-GS115 through electrotransformation, and the strain delta PAS _ chr-1-0033 delta pgi-GS115(ino +) engineering strain is obtained through screening.
EXAMPLE 4 Shake flask culture of different strains and detection of inositol expression level
After the strains which are verified to be correct are activated, single colonies on the plate are picked, inoculated into 5mL YPD liquid culture medium together with the wild type GS115, and cultured for 18h at 30 ℃ and 220 r/min. Then inoculated into a shake flask containing 50mL of inositol-free fermentation medium (6 g/L disodium hydrogen phosphate, 6g/L potassium dihydrogen phosphate, 8g/L ammonium chloride, 3g/L magnesium sulfate, 10g/L sucrose, 20g/L glycerol, 10mg/L histidine) at an inoculation amount of 1% for secondary expansion culture. Inoculating the second-stage seed liquid to obtain thallus OD6000.2 was inoculated into a 250mL Erlenmeyer flask containing 100mL inositol-free fermentation medium.
Inoculating different strains into a fermentation medium (6 g/L disodium hydrogen phosphate, 6g/L potassium dihydrogen phosphate, 8g/L ammonium chloride, 3g/L magnesium sulfate, 10g/L sucrose, 20g/L glycerol and 10mg/L histidine), culturing at 30 ℃ and 220r/min for 50h, centrifuging part of the fermentation liquid (10000r/min and 3min), filtering the supernatant with a 0.45 mu m filter in a sample bottle, and detecting the content of inositol by using a Shimadzu gas chromatograph GC-Plus. The column was RTX-1701(30 m.times.0.25 mm. times.0.25 μm), programmed: sample inlet temperature: 280 ℃; detector temperature: 300 ℃; carrier gas nitrogen gas: 1.06 mL/min; hydrogen flow rate: 40 mL/min; air: 400 mL/min; no flow diversion; sample introduction amount: 1 mu L of the solution; temperature programming: 0min at 120 ℃, 20min at 190 ℃ and 10min at 220 ℃. The inositol production of the different strains is shown in table 1.
TABLE 1 inositol production by different strains
Strain name Inositol yield (g/L)
GS115 0
△pgi-GS115 0
△PAS_chr-1_0033△pgi-GS115 1.015
△PAS_chr-1_0033△pgi-GS115(ino+) 3.202
Example 5 Δ PAS _ chr-1_0033 Δ pgi-GS115(ino +) engineering bacteria culture in 5L fermenter
The delta PAS _ chr-1_0033 delta pgi-GS115(ino +) engineering bacteria transformant is cultured in a YPG culture medium until the light reaches the YPG culture mediumDensity value>20, the YPG culture was used as a seed bacterium in a fermenter, and the seed bacterium was added to a 5L fermenter containing 3L of a basic salt medium (dipotassium hydrogenphosphate 10g/L, dipotassium hydrogenphosphate 3g/L, sodium chloride 0.2g/L, ammonium chloride 1g/L, magnesium sulfate 0.4g/L, citric acid 1.4g/L, 20% glycerin) at a ratio of 1:20, the dissolved oxygen in the fermenter was set at 30%, and the adjustment of the dissolved oxygen was controlled in series with the stirrer of the fermenter. When the glycerol in the basic salt culture medium is exhausted, the glycerol with the volume percentage of 70 percent (700ml of glycerol, 288ml of water and 12ml of PTM1 microelement solution) is supplemented, and the glycerol is supplemented by the following method: adding 8ml/h after 0-8h, 16ml/h after 9-16h, and adding 24ml/h after 17h, when the thallus OD600Glycerol addition was stopped when 350 was reached. After the fermentation was completed, a part of the fermentation broth was centrifuged (10000r/min, 5min), the supernatant was filtered through a 0.45 μm filter in a sample bottle, and the content of inositol was measured to be 32.3g/L using Shimadzu liquid chromatograph LC 2010Plus, and the results are shown in FIG. 7.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Sequence listing
<110> Shandong Fuyang Biotechnology Ltd
<120> construction method of pichia pastoris engineering bacteria for producing inositol
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 38
<212> DNA
<213> Artificial Sequence
<400> 1
acttagaaac gttgctttga cgtaataggt cacctgtg 38
<210> 2
<211> 41
<212> DNA
<213> Artificial Sequence
<400> 2
ggcactggtc aacttggcca ttttatcaat tggttggagt t 41
<210> 3
<211> 36
<212> DNA
<213> Artificial Sequence
<400> 3
cgaggagcag gactgaggcg ttctagttat agagat 36
<210> 4
<211> 36
<212> DNA
<213> Artificial Sequence
<400> 4
ctaaacatcc caaagttcaa aaactcattg ctggct 36
<210> 5
<211> 41
<212> DNA
<213> Artificial Sequence
<400> 5
aactccaacc aattgataaa atggccaagt tgaccagtgc c 41
<210> 6
<211> 36
<212> DNA
<213> Artificial Sequence
<400> 6
atctctataa ctagaacgcc tcagtcctgc tcctcg 36
<210> 7
<211> 1683
<212> DNA
<213> Artificial Sequence
<400> 7
atgccgtctc tattgcaaga ggacaatgct actttcaagc tcgcatccga actaccagct 60
ttcgaagagc taaaagagct ttataagtca aagggaaaga acttttctgc caaacaggct 120
ttccaaaagg atccagccag atcttccaag ttcagccaca ctttcaagaa cttcgacggg 180
actgaggtgt ttttcgactt ttccaagaac ttgatcgatg atgagattct cgccaaactg 240
ttcgacttgg ccagacaggc aaacgtcgag aaactccgaa acgagatgtt tgccggagaa 300
catattaatg tcacagagga cagggctgtt ttccacgtcg ctctgagaaa cagagctaac 360
cgcccaatgt acgttgacgg caagaacgtc gccccagaag ttgatagtgt tttgcaacat 420
atgaaggagt tctctacgca ggttcgcgat ggtacctgga agggatacac tggtaagcag 480
atcactgatg tggtcaacat tggtatcgga ggctctgact tgggtccagt catggtgaca 540
gaggcattga agccttacgc ccaggaagga ctgcatgttc acttcgtatc caacgtggac 600
ggtacccata ttgctgagac tctaaaatac ttggatcctg agtctactct tttcttgatt 660
gcatccaaga ctttcacaac cgctgaaacc atccgtaacg ccaatactgc taaggactgg 720
ttcctttcga aaactggtaa caaaagtgag gcaattgcca agcattttgc tgctttatcc 780
acaaatgccg aggaggtcgc aaagttcggt atcgacacta agaatatgtt cggttttgaa 840
aactgggttg gtggacgtta ctctgtgtgg tctgctatcg gtctttcagt tgccatctac 900
attggttttg acaactttga ggacttcttg aagggtgccg aagccgtgga cagacatttc 960
ctggaaactc ctctggagca aaacatccca gttattggtg gactactctc cgtttggtat 1020
actaacttct ttggaagtca gacacatttg gtcactccat ttgaccaata tatgcacaga 1080
ttccctgcct acttacaaca attgtccatg gaatccaacg gtaaatctgt taccaagggc 1140
aatgttttcg ccaactacag caccggccct gtcgtctttg gtgagccaac aacaaatgct 1200
caacattcat tcttccaatt ggtgcatcaa ggtactcatt tgatccctgc cgatttcatt 1260
ttggctgcaa aatcccacaa ccctgttgca aacaacgctc accaaatctt gttggcatct 1320
aacttcttgg ctcaagccga gtctttattg ctaggaaaga ctgaagagga agtagctgct 1380
gctggtgcta ctggtggtct aattccacac aaagtatttt caggtaacag accaactaca 1440
tctattctga cacagaaaat cactcccgca accttaggtt ctttgatcgc ttattatgag 1500
cacgtcacat tcaccgaagg agctatatgg aacatcaact catttgatca atggggtgtt 1560
gagctaggaa aggttctagc caaggctgtc cagaaagatc tgcaggatga cagtgccaac 1620
gttgaagaaa gccacgactc atccactgct caattgatca agaagttcaa agcttgggct 1680
taa 1683
<210> 8
<211> 36
<212> DNA
<213> Artificial Sequence
<400> 8
cgttagccaa tagtgtccct gcattctggt tcctcc 36
<210> 9
<211> 40
<212> DNA
<213> Artificial Sequence
<400> 9
gtattctggg cctccatgtc tgtttggcag attctgtgtc 40
<210> 10
<211> 41
<212> DNA
<213> Artificial Sequence
<400> 10
tgaatgctgg tcgctatact gattattcta tagatttagg a 41
<210> 11
<211> 30
<212> DNA
<213> Artificial Sequence
<400> 11
tttggctcgt tcgactgcca tggtcgtcaa 30
<210> 12
<211> 40
<212> DNA
<213> Artificial Sequence
<400> 12
gacacagaat ctgccaaaca gacatggagg cccagaatac 40
<210> 13
<211> 41
<212> DNA
<213> Artificial Sequence
<400> 13
tcctaaatct atagaataat cagtatagcg accagcattc a 41
<210> 14
<211> 1167
<212> DNA
<213> Artificial Sequence
<400> 14
atgagtaaac gaaaacttac aggggaatac tcaactgatg gtgacgaaaa cagagaagtt 60
attgccatag aagctctcaa ccaacttcga aataatgggt ccacttctcc atcagtagga 120
gtagaacagg atctagactc cgcacaattg cccccgatgg gcaaagtgga ttccaccacc 180
accaagctga tcgacaaagt tacttcatac cctattattt ctactggtat caactatatg 240
tggcaacgaa atctagtcat agcaggaaac tatatcaaag gcgaatcttc caaaaaagaa 300
gtggttacaa ccaaacgtca aaagacaact accaacgatt cgaaacctga agaaaggtcg 360
gctccatcgt acattcgtga caattccaga ttacgacacc ttcaagatct caaagacatt 420
ggaatgatta atttcaacct ggaaagcaga caaaaattgc aaatgttaat taacttttta 480
aaactgggga acaggcaact gaatcaacgt attgaaaaat tgatcgtaga gttacgtcgg 540
cagcagcgag gagacggtga cgacgacact gaaacggaaa ccattgttcc agatgcaccc 600
tcagggaaag acagtgaatc taatagatca aggtcctctt ccattacgag tgtccaaacc 660
gtctatgaag atgcaaccag cacagggttg gcatctccca atttgaacca agtcaaccat 720
aagttggacc aacacttcaa caaccagccg ctgaaccagg tgaaaaatga cattgttacc 780
actgtcaaaa gaatagttaa tgttgtatcc aagtttagtg ggtctgcatt acctgaacct 840
gcacggtcaa atgtacgaga agtactctta aaactgcctg ataactgggc aaactcagtt 900
ttacctcttg tggaaggtga aggcgctggc gactcccctg ccacagcaaa cacaactgaa 960
agatctctat tatctgaccc caacggtcgt gttcttgttt tagctcagga atcgctcgac 1020
atggtcacca aagtgatcaa gttctgtagt gacactcttg atagggcaga ccaatggaat 1080
cttaacaagc aaattgaaca aaagacccat ttgattcaca agctagaacg aattaataaa 1140
cacaaaccgg gggaaaagca agaatag 1167
<210> 15
<211> 1578
<212> DNA
<213> Artificial Sequence
<400> 15
atgaccatcc aatacacccc aaaggttcaa gttaacaccg acaaggctag atacaccgag 60
aacgagttgt tgaccgacta cacctacgag aacaccatcg ttgagaagca agctgacggt 120
acctacaacg ttaccccaac ctccttggac ttcgagttca aggttgactt gaagacccca 180
aagaccggtt tgttgttggt tggtttgggt ggtaacaacg gtaccacctt ggttggttcc 240
gttttggcta acaagcacaa catctccttc gagaccaaga ccggtatcca acaaccaaac 300
tactacggtt ccgttaccca agcttccacc gttaagttgg gtatcgactc caacggtaga 360
gacgtttacg ctccattcaa ctccttgttg ccattggttc acccaaacga cttcgttgtt 420
ggtggttggg acatctccgg tttggacttg gcttcctcca tgagaagatc ccaagttttg 480
caaccagact tggttagaaa gttggagcca tacatgaagg acatcgttcc attgccatcc 540
gtttactacc cagacttcat cgctgctaac caaaacgaga gagctgacaa ctgcttcaac 600
agagagggta aggacggtga ggtttccacc aagggtaagt ggtcccacgt tgagagaatc 660
agatccgaca tcgctgagtt caagcaaaag aacgacttgg acaaggttat cgttttgtgg 720
accgctaaca ccgagagata cgctgagttg atcccaggtg ttaacgacac cgctgagaac 780
ttgatcaagg ctatcaagaa cgaccacgag gaggtttccg cttccaccat cttcgctgtt 840
gcttgcatct tggacaagat cccatacatc aacggttccc cacaaaacac cttcgttcca 900
ggttgcatcg agttggctga gaccgagggt tccttcatcg gtggtgacga cttcaagtcc 960
ggtcaaacca agttgaagtc cgttttggct caattcttgg ttgacgctgg tatcagacca 1020
gtttccatcg cttcctacaa ccacttgggt aacaacgacg gttacaactt gtccgctcca 1080
caacaattca gatccaagga gatctccaag gcttccgttg ttgacgacat gatcgagtcc 1140
aacgagatct tgtacaacga gaagaacggt aacaccatcg accactgcat cgttatcaag 1200
tacatgaagg ctgttggtga cgacaaggtt gctatggacg agtaccactc cgagttgatg 1260
ttgggtggtc acaacaccat ctccatccac aacatctgcg aggactcctt gttggctacc 1320
ccattgatca tcgacttggt tgttatggct gagttcttgt ccagagtttc ctacaagaag 1380
aagggtgacg ctgagtacga gtccttgcac tccgttttgt ccttcttgtc ctactggttg 1440
aaggctccat tgaccagacc aggttaccaa gctatcaacg gtttgaacaa gcaaagagct 1500
ggtttggaca acttcttgag aatgttgatc ggtttgccaa cccaaaacga gttgagattc 1560
gaggagagat tgcaatag 1578

Claims (3)

1. The construction method of the pichia pastoris engineering bacteria for producing inositol is characterized by comprising the following specific steps:
(1) knocking out a glycolysis key gene pgi by using pichia pastoris GS115 as an initial strain to obtain a pgi gene knocked-out strain delta pgi-GS 115;
(2) knocking out a negative regulation gene PAS _ chr-1_0033 of inositol biosynthesis of the strain delta pgi-GS115 to obtain a strain delta PAS _ chr-1_0033 delta pgi-GS115 with the PAS _ chr-1_0033 gene knocked out;
(3) an inositol-3-phosphate synthase gene ino1 is overexpressed in a strain delta PAS _ chr-1_0033 delta pgi-GS115, and a pichia pastoris engineering strain delta PAS _ chr-1_0033 delta pgi-GS115(ino +) for producing inositol is constructed.
2. The construction method of the pichia pastoris engineering bacterium for producing inositol according to claim 1, wherein in the step (1) and the step (2), the pgi gene and the PAS _ chr-1_0033 gene are knocked out respectively by using a homologous recombination technology.
3. The construction method of the pichia pastoris engineered strain capable of producing inositol according to claim 1, wherein the pichia pastoris engineered strain capable of producing inositol is applied to the preparation of products containing inositol.
CN202010653538.8A 2020-07-08 2020-07-08 Construction method of pichia pastoris engineering bacteria for producing inositol Active CN113913451B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010653538.8A CN113913451B (en) 2020-07-08 2020-07-08 Construction method of pichia pastoris engineering bacteria for producing inositol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010653538.8A CN113913451B (en) 2020-07-08 2020-07-08 Construction method of pichia pastoris engineering bacteria for producing inositol

Publications (2)

Publication Number Publication Date
CN113913451A true CN113913451A (en) 2022-01-11
CN113913451B CN113913451B (en) 2023-05-26

Family

ID=79231828

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010653538.8A Active CN113913451B (en) 2020-07-08 2020-07-08 Construction method of pichia pastoris engineering bacteria for producing inositol

Country Status (1)

Country Link
CN (1) CN113913451B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011055722A (en) * 2009-09-07 2011-03-24 Nippon Shokubai Co Ltd Method for producing inositol
WO2013125666A1 (en) * 2012-02-23 2013-08-29 株式会社日本触媒 Microorganism producing inositol with high yield, and method for manufacturing inositol by using same
US20190322991A1 (en) * 2016-06-30 2019-10-24 Cj Cheiljedang Corporation Method for enzymatically preparing highly concentrated myo-inositol

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011055722A (en) * 2009-09-07 2011-03-24 Nippon Shokubai Co Ltd Method for producing inositol
WO2013125666A1 (en) * 2012-02-23 2013-08-29 株式会社日本触媒 Microorganism producing inositol with high yield, and method for manufacturing inositol by using same
US20190322991A1 (en) * 2016-06-30 2019-10-24 Cj Cheiljedang Corporation Method for enzymatically preparing highly concentrated myo-inositol

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
黄贞杰等: "代谢工程改造酿酒酵母合成肌醇", 《微生物学报》 *

Also Published As

Publication number Publication date
CN113913451B (en) 2023-05-26

Similar Documents

Publication Publication Date Title
CN110272858B (en) Bacillus coagulans for high yield of L-lactic acid and application thereof
CN114480240A (en) Genetic engineering bacterium for producing fucosyllactose and production method thereof
CN112899177B (en) Recombinant yarrowia lipolytica expressing myrosinase TGG4 and application thereof
CN114874964B (en) Construction method and application of recombinant escherichia coli for high yield of 2&#39; -fucosyllactose
CN114621968A (en) Tetrahydropyrimidine biosynthesis gene cluster, mutant and method for preparing tetrahydropyrimidine
CN109207373B (en) Microbial strain for high yield of citric acid and method for producing citric acid by fermenting starch sugar through microbial strain
CN107257851A (en) Positive influences are natural or combination of bacterial chaperonin of physiology of eukaryotic of engineering
CN102827853B (en) Halogenohydrin dehalogenation enzyme gene mutant and application thereof
CN105238797B (en) A kind of mutator of gshF genes of Streptococcusagalactiae and its application
CN104789586A (en) Escherichia coli genome integration vector, genetically engineered bacterium and application of genetically engineered bacterium to xylitol production
CN108103049B (en) Thermophilic L-asparaginase mutant and screening and fermenting method thereof
CN108588108B (en) Preparation method and application of bacillus for efficiently metabolizing glycerol
CN113913451B (en) Construction method of pichia pastoris engineering bacteria for producing inositol
CN111500479B (en) Construction and application of non-methanol-induced dual-promoter pichia pastoris engineering bacteria
WO2022088263A1 (en) Recombinant escherichia coli for efficient production of succinic acid and construction method for recombinant escherichia coli
CN114107358B (en) Construction method of heat-resistant aspergillus niger engineering bacteria for increasing content of stress trehalose
CN104878031B (en) A kind of alginate lyase SHA-2 genes and its expression vector
CN114717124A (en) Saccharomyces cerevisiae engineering strain for high yield of ergosterol, construction method and application
CN112251390A (en) Genetically engineered bacterium for synthesizing vanillin by converting lignin-containing biomass and application thereof
CN107384923B (en) Promoter pYLG and application thereof in construction of candida tropicalis with high yield of long-chain dicarboxylic acid
CN115011536B (en) Engineering bacterium for producing high optical purity D-lactic acid by double anaerobic promoters and preparation method and application thereof
CN106957853B (en) A method of yeast cells is improved to composite inhibitor tolerance
CN105087515B (en) A kind of preparation method and application of purine nucleoside phosphorylase
CN105586281B (en) Proline is for enhancing purposes, the purposes of gene, expression vector of bacterial strain tolerance and application thereof, bacterial strain and application thereof
CN104403956A (en) Construction and application of xylitol high-temperature and high-yield engineered strains

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant